|
|
|
|
|
|
|
|
|
|
|
|
|
19.12.25 - 22:12
|
Lifeward Appoints Bob Marshall as Chairman of the Board (GlobeNewswire EN)
|
|
|
MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, Dec. 19, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd., (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global leader in innovative medical technology designed to transform the lives of people with physical limitations or disabilities, announced today that its Board of Directors has appointed Bob Marshall as Chairman of the Board, effective January 1, 2026. He replaces Joseph Turk, who will transition off the Board in connection with his new position at Fresenius Medical Care....
|
|
|
17.12.25 - 16:06
|
RIS Rx Appoints Stuart McGuigan to Board of Directors (Business Wire)
|
|
|
IRVINE, Calif.--(BUSINESS WIRE)--RIS Rx, a healthcare technology company offering gross-to-net (GTN) revenue protection and saving more than $1 billion for the world's leading pharmaceutical manufacturers, today announced the appointment of Stuart McGuigan to its Board of Directors.
Mr. McGuigan is an expert technology and healthcare executive with more than three decades of experience driving digital transformation and operational excellence in complex global organizations. Most recently, he served as Interim Global Chief Information Officer for Fresenius Medical Care, where he oversaw technology strategy and execution across the company's global dialysis and renal care operations. Prior to this role, Mr. McGuigan was Chief Information Officer of the U.S. Department of State, where he established strategic direction and provided oversight for multibillion-dollar technology programs. Prior to that, he led global information technology for Johnson & Johnson and held senior technology leadership roles at ...
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
03.12.25 - 13:42
|
Fresenius Medical Care (FMC) St Buy (DPA-AFX)
|
|
|
HAMBURG (dpa-AFX Analyser) - Die Privatbank Berenberg hat die Einstufung für FMC am zweiten Tag einer Investorenveranstaltung mit einem Kursziel von 60 Euro auf "Buy" belassen. Die Konzernchefin habe detaillierten Einblick in den US-Dialysemarkt gewährt, ......
|
|
|
|
|
01.12.25 - 12:39
|
Fresenius Medical Care (FMC) St Sell (DPA-AFX)
|
|
|
ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat die Einstufung für FMC mit einem Kursziel von 38 Euro auf "Sell" belassen. Analyst Graham Doyle blieb in seiner Einschätzung vom Freitagabend skeptisch, ob der Dialysekonzern die hohen Markterwartungen ......
|
|
|
|
|
|
|
24.11.25 - 13:36
|
Fresenius Medical Care (FMC) St Equal Weight (DPA-AFX)
|
|
|
LONDON (dpa-AFX Analyser) - Die britische Investmentbank Barclays hat das Kursziel für FMC von 51 auf 48 Euro gesenkt und die Einstufung auf "Equal Weight" belassen. Die Aktienkurse der europäischen Medizintechnik-Unternehmen hätten sich im laufenden ......
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
